O'Shaughnessy Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,413
Closed -$33.2K 2120
2024
Q2
$33.2K Buy
+1,413
New +$35.7K ﹤0.01% 1755
2022
Q1
Sell
-1
Closed 1276
2021
Q4
$0 Buy
+1
New +$69 ﹤0.01% 1329

Other funds holding ARKG

O'Shaughnessy Asset Management's ARKG Position: Q3 2024 in Review

O'Shaughnessy Asset Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2024, closing a stake of 1,413 shares — an estimated $33.2K sold.

O'Shaughnessy Asset Management first reported a position in ARKG in Q4 2021 and held it in 2 quarters. The position peaked at $33.2K in Q2 2024. 238 funds tracked by Wall St. Rank hold ARKG as of Q3 2024.

  • O'Shaughnessy Asset Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2024 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 1,413 ARK Genomic Revolution ETF shares in Q3 2024, an estimated $33.2K.
  • O'Shaughnessy Asset Management first reported a position in ARK Genomic Revolution ETF in Q4 2021 and held it in 2 quarters.
  • O'Shaughnessy Asset Management's ARK Genomic Revolution ETF position peaked at $33.2K in Q2 2024.
  • 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2024.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.